Response durability after cessation of immune checkpoint inhibitors in patients with metastatic Merkel cell carcinoma: a retrospective multicenter DeCOG study.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3313, doi. 10.1007/s00262-021-02925-4

By:

• Stege, H. M.;
• Haist, M.;
• Schultheis, S.;
• Fleischer, M. I.;
• Mohr, P.;
• Ugurel, S.;
• Terheyden, P.;
• Thiem, A.;
• Kiecker, F.;
• Leiter, U.;
• Becker, J. C.;
• Meissner, M.;
• Kleeman, J.;
• Pföhler, C.;
• Hassel, J.;
• Grabbe, S.;
• Loquai, C.

Publication type:

Article